Epilepsy: Fractures and the role of cumulative antiepileptic drug load

Acta Neurologica Scandinavica

Volumn 125, Issue 1, 2012, Pages 54-59

  Beerhorst, K ^a,b,c   Schouwenaars, F M ^d   Tan, I Y ^e   Aldenkamp, A P ^a,b,e  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Sittard Geleen Heerlen   (Netherlands)

^d Stichting ORO   (Netherlands)

^e EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

Author keywords

Antiepileptic drugs; Bone mineral density; Cumulative drug load; Epilepsy; Fractures; Osteoporosis

Indexed keywords

ALENDRONIC ACID; ANTICONVULSIVE AGENT; CAFFEINE; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; RISEDRONIC ACID; TOPIRAMATE; VALPROIC ACID;

ADULT; AGED; ALCOHOL CONSUMPTION; AMBULATORY MONITORING; ARTICLE; BODY MASS; BONE DENSITOMETRY; CERVICAL SPINE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE DURATION; EPILEPSY; FEMALE; HEALTH STATUS; HIGH RISK POPULATION; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OSTEOPOROSIS; SMOKING; TERTIARY HEALTH CARE;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; BONE DENSITY; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES;

EID: 84155187389     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2011.01509.x     Document Type: Article

References (29)

1. Kruse R. [Osteopathies in antiepileptic long-term therapy (preliminary report)]. Monatsschr Kinderheilkd 1968;116:378-81.
2. Ashworth B, Horn DB. Evidence of osteomalacia in an outpatient group of adult epileptics. Epilepsia 1977;18:37-43.
3. Lidgren L, Walloe A. Incidence of fracture in epileptics. Acta Orthop Scand 1977;48:356-61.
4. Andress DL, Ozuna J, Tirschwell D et al. Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch Neurol 2002;59:781-6.
5. Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj Fuleihan G. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 2002;9:1348-53.
6. Stephen LJ, McLellan AR, Harrison JH et al. Bone density and antiepileptic drugs: a case-controlled study. Seizure 1999;8:339-42.
7. Sato Y, Kondo I, Ishida S et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 2001;57:445-9.
8. Boluk A, Guzelipek M, Savli H, Temel I, Ozisik HI, Kaygusuz A. The effect of valproate on bone mineral density in adult epileptic patients. Pharmacol Res 2004;50:93-7.
9. Pack AM, Morrell MJ, Marcus R et al. Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol 2005;57:252-7.
10. Mintzer S, Boppana P, Toguri J, DeSantis A. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia 2006;47:510-5.
11. Nissen-Meyer LS, Svalheim S, Tauboll E et al. Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism. Epilepsia 2007;48:1850-60.
12. El-Hajj Fuleihan G, Dib L, Yamout B, Sawaya R, Mikati MA. Predictors of bone density in ambulatory patients on antiepileptic drugs. Bone 2008;43:149-55.
13. Lado F, Spiegel R, Masur JH, Boro A, Haut SR. Value of routine screening for bone demineralization in an urban population of patients with epilepsy. Epilepsy Res 2008;78:155-60.
14. Petty SJ, Paton LM, O'Brien TJ et al. Effect of antiepileptic medication on bone mineral measures. Neurology 2005;65:1358-65.
15. Valsamis HA, Arora SK, Labban B, McFarlane SI. Antiepileptic drugs and bone metabolism. Nutr Metab (Lond) 2006;3:36.
16. Souverein PC, Webb DJ, Weil JG, Van Staa TP, Egberts AC. Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy. Neurology 2006;66:1318-24.
17. Adams JE. Quantitative computed tomography. Eur J Radiol 2009;71:415-24.
18. Bergot C, Laval-Jeantet AM, Hutchinson K, Dautraix I, Caulin F, Genant HK. A comparison of spinal quantitative computed tomography with dual energy X-ray absorptiometry in European women with vertebral and nonvertebral fractures. Calcif Tissue Int 2001;68:74-82.
19. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 1994;4:368-81.
20. Vestergaard P. Epilepsy, osteoporosis and fracture risk - a meta-analysis. Acta Neurol Scand 2005;112:277-86.
21. Lyngstad-Brechan MA, Tauboll E, Nakken KO et al. Reduced bone mass and increased bone turnover in postmenopausal women with epilepsy using antiepileptic drug monotherapy. Scand J Clin Lab Invest 2008;68:759-66.
22. Schrager S. Osteoporosis in women with disabilities. J Womens Health (Larchmt) 2004;13:431-7.
23. Jaffe JS, Timell AM, Elolia R, Thatcher SS. Risk factors for low bone mineral density in individuals residing in a facility for the people with intellectual disability. J Intellect Disabil Res 2005;49:457-62.
24. Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of antiepileptic drugs. Epilepsia 2004;45:1330-7.
25. Persson HB, Alberts KA, Farahmand BY, Tomson T. Risk of extremity fractures in adult outpatients with epilepsy. Epilepsia 2002;43:768-72.
26. Tsiropoulos I, Andersen M, Nymark T, Lauritsen J, Gaist D, Hallas J. Exposure to antiepileptic drugs and the risk of hip fracture: a case-control study. Epilepsia 2008;49:2092-9.
27. Kulak CA, Borba VZ, Bilezikian JP, Silvado CE, Paola L, Boguszewski CL. Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs. Arq Neuropsiquiatr 2004;62:940-8.
28. Pack AM, Gidal B, Vazquez B. Bone disease associated with antiepileptic drugs. Cleve Clin J Med 2004;71(Suppl. 2):S42-8.
29. Lee RH, Lyles KW, Colon-Emeric C. A review of the effect of anticonvulsant medications on bone mineral density and fracture risk. Am J Geriatr Pharmacother 2010;8:34-46.